Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- PMID: 22526604
- DOI: 10.1007/s00125-012-2534-0
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Erratum in
- Diabetologia. 2013 Mar;56(3):680
Similar articles
-
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.Diabetologia. 2015 Mar;58(3):429-42. doi: 10.1007/s00125-014-3460-0. Epub 2015 Jan 13. Diabetologia. 2015. PMID: 25583541 No abstract available.
-
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19. Diabetes Care. 2012. PMID: 22517736 Free PMC article. Review. No abstract available.
-
Do published ADA studies support the ADA-EASD position statement for the management of hyperglycaemia in type 2 diabetics?Ann Endocrinol (Paris). 2013 Jul;74(3):207-10. doi: 10.1016/j.ando.2013.04.001. Epub 2013 Jun 6. Ann Endocrinol (Paris). 2013. PMID: 23747137
-
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetes Care. 2007 Jan;30(1):193-4. doi: 10.2337/dc06-2060. Diabetes Care. 2007. PMID: 17192373 No abstract available.
-
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetologia. 2006 Aug;49(8):1711-21. doi: 10.1007/s00125-006-0316-2. Diabetologia. 2006. PMID: 16802130 No abstract available.
Cited by
-
Comparison of Efficacy and Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy in Patients With Type 2 Diabetes.Cureus. 2021 Apr 3;13(4):e14268. doi: 10.7759/cureus.14268. Cureus. 2021. PMID: 33954073 Free PMC article.
-
Association between hypoglycemia and fall-related events in type 2 diabetes mellitus: analysis of a U.S. commercial database.J Manag Care Spec Pharm. 2015 Mar;21(3):243-53. doi: 10.18553/jmcp.2015.21.3.243. J Manag Care Spec Pharm. 2015. PMID: 25726033 Free PMC article.
-
ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter].Diabetologia. 2012 Oct;55(10):2856-2857. doi: 10.1007/s00125-012-2669-z. Epub 2012 Aug 2. Diabetologia. 2012. PMID: 22854891 No abstract available.
-
Long-term effects of a telemedically-assisted lifestyle intervention on glycemic control in patients with type 2 diabetes - A two-armed randomised controlled trial in Germany.J Diabetes Metab Disord. 2023 Oct 25;23(1):519-532. doi: 10.1007/s40200-023-01290-6. eCollection 2024 Jun. J Diabetes Metab Disord. 2023. PMID: 38932898 Free PMC article.
-
β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians.Curr Diab Rep. 2015 Jun;15(6):602. doi: 10.1007/s11892-015-0602-9. Curr Diab Rep. 2015. PMID: 25944304 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials